Eagle Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Buy
1,110
+13
+1% +$15.3K 0.94% 23
2026
Q2
$1.32M Sell
1,097
-351
-24% -$359K 1% 24
2026
Q1
$1.33M Sell
1,448
-808
-36% -$819K 1.23% 17
2025
Q4
$2.42M Buy
+2,256
New +$2.16M 2.07% 13

Other funds holding LLY

Eagle Wealth Advisors's LLY Position: Q3 2026 in Review

Eagle Wealth Advisors increased its Eli Lilly (LLY) stake by 1.2% in Q3 2026, buying an estimated $15.3K and bringing the position to 1,110 shares worth $1.28M. The position accounts for 0.94% of the portfolio, ranked #23.

Eagle Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.42M in Q4 2025. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Eagle Wealth Advisors held 1,110 shares of Eli Lilly worth $1.28M as of Q3 2026.
  • Eagle Wealth Advisors bought 13 Eli Lilly shares in Q3 2026, an estimated $15.3K.
  • Eli Lilly made up 0.94% of Eagle Wealth Advisors's portfolio in Q3 2026, its #23 holding.
  • Eagle Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Eagle Wealth Advisors's Eli Lilly position peaked at $2.42M in Q4 2025.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Eagle Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.